Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,181 | 93 | 75.2% |
| Travel and Lodging | $620.07 | 2 | 21.4% |
| Education | $99.99 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $769.67 | 6 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $485.18 | 19 | $0 (2024) |
| ABBVIE INC. | $327.03 | 18 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $243.98 | 5 | $0 (2024) |
| UCB, Inc. | $176.49 | 6 | $0 (2024) |
| Journey Medical Corporation | $120.89 | 2 | $0 (2023) |
| GENZYME CORPORATION | $116.96 | 4 | $0 (2024) |
| Lilly USA, LLC | $100.30 | 7 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $99.99 | 1 | $0 (2024) |
| PFIZER INC. | $79.53 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,293 | 54 | E.R. Squibb & Sons, L.L.C. ($304.50) |
| 2023 | $305.61 | 19 | ABBVIE INC. ($61.98) |
| 2022 | $1,290 | 22 | Allergan, Inc. ($769.67) |
| 2021 | $12.74 | 1 | Janssen Pharmaceuticals, Inc ($12.74) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: Immunology | ||||||
| 12/04/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.17 | General |
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $7.65 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.01 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Dermatology | ||||||
| 10/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Dermatology | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.65 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.81 | General |
| Category: Immunology | ||||||
| 09/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.81 | General |
| Category: Immunology | ||||||
| 09/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: DERMATOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $115.15 | General |
| Category: Dermatology | ||||||
| 08/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $93.24 | General |
| Category: Immunology | ||||||
| 08/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Immunology | ||||||
| 07/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 867 | 1,238 | $147,517 | $51,989 |
| 2022 | 9 | 510 | 712 | $78,449 | $30,360 |
| 2021 | 3 | 163 | 165 | $170,028 | $12,361 |
| 2020 | 3 | 143 | 143 | $158,150 | $10,863 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 179 | 226 | $33,155 | $12,799 | 38.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 134 | 172 | $32,882 | $11,630 | 35.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 113 | 131 | $22,395 | $7,213 | 32.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 95 | 95 | $17,287 | $6,169 | 35.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 102 | 136 | $15,176 | $4,406 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 70 | 83 | $7,681 | $3,028 | 39.4% |
| 10040 | Acne surgery | Office | 2023 | 26 | 30 | $5,843 | $1,970 | 33.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 43 | 43 | $5,084 | $1,641 | 32.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 71 | 285 | $3,199 | $1,239 | 38.7% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 14 | $2,873 | $1,203 | 41.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 23 | $1,941 | $690.84 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 103 | $15,407 | $6,509 | 42.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 66 | 79 | $15,410 | $5,873 | 38.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 64 | 64 | $11,816 | $4,847 | 41.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 58 | 61 | $10,762 | $3,940 | 36.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 89 | 103 | $11,733 | $3,752 | 32.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 47 | 53 | $4,976 | $2,096 | 42.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 28 | 28 | $3,385 | $1,369 | 40.4% |
| 10060 | Simple or single drainage of skin abscess | Office | 2022 | 12 | 12 | $2,530 | $1,003 | 39.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 56 | 209 | $2,431 | $970.01 | 39.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 61 | 62 | $72,292 | $5,498 | 7.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 84 | 85 | $66,470 | $4,408 | 6.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 18 | 18 | $31,266 | $2,454 | 7.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 51 | 51 | $59,466 | $4,366 | 7.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 28 | 28 | $48,636 | $3,629 | 7.5% |
About Charles Middleton, PA-C
Charles Middleton, PA-C is a Physician Assistant healthcare provider based in Marmora, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1972810836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Charles Middleton, PA-C has received a total of $2,901 in payments from pharmaceutical and medical device companies, with $1,293 received in 2024. These payments were reported across 96 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,181).
As a Medicare-enrolled provider, Middleton has provided services to 1,683 Medicare beneficiaries, totaling 2,258 services with total Medicare billing of $105,572. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Marmora, NJ
- Active Since 09/13/2010
- Last Updated 06/29/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1972810836
Products in Payments
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $769.67
- Sotyktu (Drug) $485.18
- DUPIXENT (Biological) $279.02
- SKYRIZI (Biological) $265.05
- ILUMYA (Biological) $243.98
- Bimzelx (Biological) $176.49
- TargaDox (Drug) $106.47
- TALTZ (Drug) $83.68
- RINVOQ (Biological) $61.98
- VTAMA (Drug) $55.98
- EUCRISA (Drug) $54.21
- CLODERM (Drug) $40.00
- ORACEA (Drug) $39.99
- Zoryve (Drug) $31.65
- COSENTYX (Biological) $28.29
- CIBINQO (Drug) $25.32
- OLUMIANT (Drug) $16.62
- ADBRY (Biological) $14.10
- SPRAVATO (Drug) $12.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.